EUBiologics

EuBiologics Co., Ltd. is a publicly traded South Korean biopharmaceutical company focused on developing vaccines against global pandemics and bacterial infectious diseases. Founded in 2010 and headquartered in Seoul (Gangnam-gu), the company is the world's largest supplier of oral cholera vaccine (OCV), having supplied more than 45 million doses under the Euvichol, Euvichol-Plus, and Euvichol-S brand names. EuBiologics also developed EuCorVac-19, a recombinant protein COVID-19 vaccine, and produces EcML (a TLR4 agonist vaccine adjuvant) and rCRM197 (a carrier protein for conjugate vaccines). In addition to its proprietary pipeline, the company provides contract research and manufacturing (CRMO) services for biopharmaceutical clients. EuBiologics is listed on the KOSDAQ exchange (ticker: 206650.KQ).